Position in MRK
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$285,655
+$18,251 QoQ
Shares Held
2,223
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
#3,202
of 3,769 holders
Holding Since
Jun 2024
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MRK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Promethos Capital, LLC holds $36,848,901 across 2 Drug Manufacturers - General names. MRK ranks #2 (0.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NVS |
Novartis AG
|
233,303 | $36,563,246 | |
| 2 | MRK |
Merck & Co., Inc.
This page
|
2,223 | $285,655 |
All Filings in MRK
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $285,655 | 2,223 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $267,404 | 2,223 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $221,361 | 2,103 | Shares | Sole | 2026-02-13 | |
| 2025-03-31 | $149,719 | 1,668 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $165,932 | 1,668 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $126,278 | 1,112 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $98,668 | 797 | Shares | Sole | 2024-08-12 | |
| No filing history on record for this holder in this stock. | ||||||